Does the media favor CNC or ELV?

In the previous week, Centene had 11 more articles in the media than Elevance Health. MarketBeat recorded 21 mentions for Centene and 10 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.11 beat Centene's score of 1.03 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 11 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MOH or CNC?

In the previous week, Centene had 13 more articles in the media than Molina Healthcare. MarketBeat recorded 21 mentions for Centene and 8 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.71 beat Centene's score of 1.03 indicating that Molina Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Molina Healthcare 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Centene 11 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, CNC or HUM?

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Centene $202.94B 0.16 -$6.67B -$10.44 N/A Humana $129.66B 0.36 $1.19B $10.57 36.63

Is CNC or HUM more profitable?

Humana has a net margin of 0.88% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Centene -2.51% 12.12% 3.20% Humana 0.88% 11.20% 3.94%

Does the media refer more to CNC or HUM?

In the previous week, Centene had 6 more articles in the media than Humana. MarketBeat recorded 21 mentions for Centene and 15 mentions for Humana. Humana's average media sentiment score of 1.15 beat Centene's score of 1.03 indicating that Humana is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 11 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Humana 9 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, OSCR or CNC?

Oscar Health has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Oscar Health $11.70B 0.73 -$443.15M $1.40 20.22 Centene $202.94B 0.16 -$6.67B -$10.44 N/A

Is OSCR or CNC more profitable?

Oscar Health has a net margin of 3.60% compared to Centene's net margin of -2.51%. Oscar Health's return on equity of 44.96% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets Oscar Health 3.60% 44.96% 7.73% Centene -2.51% 12.12% 3.20%

Does the media refer more to OSCR or CNC?

In the previous week, Oscar Health had 1 more articles in the media than Centene. MarketBeat recorded 22 mentions for Oscar Health and 21 mentions for Centene. Centene's average media sentiment score of 1.03 beat Oscar Health's score of 0.78 indicating that Centene is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oscar Health 7 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 11 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, HQY or CNC?

HealthEquity has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 6.78 $215.20M $2.67 39.91 Centene $202.94B 0.16 -$6.67B -$10.44 N/A

Is HQY or CNC more profitable?

HealthEquity has a net margin of 17.25% compared to Centene's net margin of -2.51%. HealthEquity's return on equity of 14.75% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.25% 14.75% 9.22% Centene -2.51% 12.12% 3.20%

Does the media favor HQY or CNC?

In the previous week, Centene had 9 more articles in the media than HealthEquity. MarketBeat recorded 21 mentions for Centene and 12 mentions for HealthEquity. Centene's average media sentiment score of 1.03 beat HealthEquity's score of 0.99 indicating that Centene is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 7 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Centene 11 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Centene (CNC) Competitors

$66.41 +0.64 (+0.97%)

As of 02:03 PM Eastern

Compare

CNC vs. ELV, MOH, HUM, OSCR, and HQY

Should you buy Centene stock or one of its competitors? MarketBeat compares Centene with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Centene include Elevance Health (ELV), Molina Healthcare (MOH), Humana (HUM), Oscar Health (OSCR), and HealthEquity (HQY). These companies are all part of the "managed healthcare" industry.

How does Centene compare to Elevance Health?

Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Centene has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market. Comparatively, Elevance Health has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market.

Centene currently has a consensus target price of $68.58, indicating a potential upside of 3.31%. Elevance Health has a consensus target price of $440.90, indicating a potential upside of 10.82%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts clearly believe Elevance Health is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65

Elevance Health has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$202.94B	0.16	-$6.67B	-$10.44	N/A
Elevance Health	$199.13B	0.43	$5.66B	$22.50	17.68

Elevance Health has a net margin of 2.47% compared to Centene's net margin of -2.51%. Elevance Health's return on equity of 14.64% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	-2.51%	12.12%	3.20%
Elevance Health	2.47%	14.64%	5.22%

In the previous week, Centene had 11 more articles in the media than Elevance Health. MarketBeat recorded 21 mentions for Centene and 10 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.11 beat Centene's score of 1.03 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	11 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elevance Health	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Elevance Health beats Centene on 11 of the 17 factors compared between the two stocks.

How does Centene compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and Centene (NYSE:CNC) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

98.5% of Molina Healthcare shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 1.4% of Molina Healthcare shares are owned by insiders. Comparatively, 0.4% of Centene shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Molina Healthcare has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market. Comparatively, Centene has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market.

Molina Healthcare currently has a consensus price target of $202.44, indicating a potential upside of 1.95%. Centene has a consensus price target of $68.58, indicating a potential upside of 3.31%. Given Centene's stronger consensus rating and higher possible upside, analysts clearly believe Centene is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Molina Healthcare	2 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.18
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

Molina Healthcare has a net margin of -0.02% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Molina Healthcare	-0.02%	3.73%	0.97%
Centene	-2.51%	12.12%	3.20%

In the previous week, Centene had 13 more articles in the media than Molina Healthcare. MarketBeat recorded 21 mentions for Centene and 8 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.71 beat Centene's score of 1.03 indicating that Molina Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Molina Healthcare	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Centene	11 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Molina Healthcare has higher earnings, but lower revenue than Centene. Molina Healthcare is trading at a lower price-to-earnings ratio than Centene, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Molina Healthcare	$44.52B	0.23	$472M	-$0.18	N/A
Centene	$202.94B	0.16	-$6.67B	-$10.44	N/A

Summary

Centene beats Molina Healthcare on 9 of the 16 factors compared between the two stocks.

How does Centene compare to Humana?

Centene (NYSE:CNC) and Humana (NYSE:HUM) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

Humana has a net margin of 0.88% compared to Centene's net margin of -2.51%. Centene's return on equity of 12.12% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	-2.51%	12.12%	3.20%
Humana	0.88%	11.20%	3.94%

Centene has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, Humana has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Centene presently has a consensus price target of $68.58, indicating a potential upside of 3.31%. Humana has a consensus price target of $391.87, indicating a potential upside of 1.21%. Given Centene's higher possible upside, equities research analysts plainly believe Centene is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Humana	1 Sell rating(s)	14 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.50

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$202.94B	0.16	-$6.67B	-$10.44	N/A
Humana	$129.66B	0.36	$1.19B	$10.57	36.63

93.6% of Centene shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 0.2% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Centene had 6 more articles in the media than Humana. MarketBeat recorded 21 mentions for Centene and 15 mentions for Humana. Humana's average media sentiment score of 1.15 beat Centene's score of 1.03 indicating that Humana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	11 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Humana	9 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Humana beats Centene on 9 of the 16 factors compared between the two stocks.

How does Centene compare to Oscar Health?

Oscar Health (NYSE:OSCR) and Centene (NYSE:CNC) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

Oscar Health has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oscar Health	$11.70B	0.73	-$443.15M	$1.40	20.22
Centene	$202.94B	0.16	-$6.67B	-$10.44	N/A

Oscar Health has a net margin of 3.60% compared to Centene's net margin of -2.51%. Oscar Health's return on equity of 44.96% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oscar Health	3.60%	44.96%	7.73%
Centene	-2.51%	12.12%	3.20%

Oscar Health currently has a consensus target price of $24.00, indicating a potential downside of 15.20%. Centene has a consensus target price of $68.58, indicating a potential upside of 3.27%. Given Centene's stronger consensus rating and higher possible upside, analysts plainly believe Centene is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oscar Health	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.33
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

Oscar Health has a beta of 2.36, indicating that its share price is 136% more volatile than the broader market. Comparatively, Centene has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

75.7% of Oscar Health shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 22.6% of Oscar Health shares are held by insiders. Comparatively, 0.4% of Centene shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Oscar Health had 1 more articles in the media than Centene. MarketBeat recorded 22 mentions for Oscar Health and 21 mentions for Centene. Centene's average media sentiment score of 1.03 beat Oscar Health's score of 0.78 indicating that Centene is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oscar Health	7 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	11 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Oscar Health beats Centene on 10 of the 16 factors compared between the two stocks.

How does Centene compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Centene (NYSE:CNC) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

In the previous week, Centene had 9 more articles in the media than HealthEquity. MarketBeat recorded 21 mentions for Centene and 12 mentions for HealthEquity. Centene's average media sentiment score of 1.03 beat HealthEquity's score of 0.99 indicating that Centene is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	7 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	11 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a net margin of 17.25% compared to Centene's net margin of -2.51%. HealthEquity's return on equity of 14.75% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Centene	-2.51%	12.12%	3.20%

HealthEquity currently has a consensus price target of $110.93, indicating a potential upside of 4.10%. Centene has a consensus price target of $68.58, indicating a potential upside of 3.27%. Given HealthEquity's stronger consensus rating and higher possible upside, research analysts clearly believe HealthEquity is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

HealthEquity has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, Centene has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 0.4% of Centene shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

HealthEquity has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.78	$215.20M	$2.67	39.91
Centene	$202.94B	0.16	-$6.67B	-$10.44	N/A

Summary

HealthEquity beats Centene on 12 of the 17 factors compared between the two stocks.

Get Centene News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNC vs. The Competition

Export

Metric	Centene	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$32.82B	$10.00B	$7.04B	$24.20B
Dividend Yield	N/A	2.55%	2.58%	3.69%
P/E Ratio	-6.36	25.65	269.97	29.10
Price / Sales	0.16	4.84	650.66	13.69
Price / Cash	14.04	25.58	28.89	19.37
Price / Book	1.63	5.31	11.26	4.91
Net Income	-$6.67B	$309.96M	$3.45B	$1.06B
7 Day Performance	4.17%	1.47%	3.62%	1.36%
1 Month Performance	-1.41%	0.67%	-0.56%	2.35%
1 Year Performance	159.50%	23.69%	77.38%	20.17%

Centene Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNC Centene	3.9012 of 5 stars	$66.41 +1.0%	$68.58 +3.3%	+156.8%	$32.79B	$202.94B	N/A	61,100
ELV Elevance Health	4.8003 of 5 stars	$383.11 +1.9%	$440.90 +15.1%	+34.0%	$83.09B	$199.13B	17.03	97,100	Positive News
MOH Molina Healthcare	2.4784 of 5 stars	$194.68 -0.5%	$202.44 +4.0%	+25.4%	$10.16B	$45.43B	N/A	19,000	Positive News
HUM Humana	4.278 of 5 stars	$374.27 +2.9%	$386.61 +3.3%	+44.2%	$44.94B	$129.66B	35.41	67,060	Positive News
OSCR Oscar Health	3.941 of 5 stars	$30.74 -1.6%	$22.00 -28.4%	+81.0%	$9.27B	$13.30B	N/A	2,305	Earnings Report Analyst Forecast Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CNC) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Centene (CNC) Competitors

CNC vs. ELV, MOH, HUM, OSCR, and HQY

How does Centene compare to Elevance Health?

Summary

How does Centene compare to Molina Healthcare?

Summary

How does Centene compare to Humana?

Summary

How does Centene compare to Oscar Health?

Summary

How does Centene compare to HealthEquity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNC vs. The Competition

Centene Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Centene (CNC) Competitors

CNC vs. ELV, MOH, HUM, OSCR, and HQY

How does Centene compare to Elevance Health?

Which has more risk & volatility, CNC or ELV?

Do analysts prefer CNC or ELV?

Which has higher valuation and earnings, CNC or ELV?

Is CNC or ELV more profitable?

Does the media favor CNC or ELV?

Do institutionals and insiders believe in CNC or ELV?

Summary

How does Centene compare to Molina Healthcare?

Do institutionals and insiders have more ownership in MOH or CNC?

Which has more risk & volatility, MOH or CNC?

Do analysts prefer MOH or CNC?

Is MOH or CNC more profitable?

Does the media prefer MOH or CNC?

Which has preferable valuation and earnings, MOH or CNC?

Summary

How does Centene compare to Humana?

Is CNC or HUM more profitable?

Which has more risk & volatility, CNC or HUM?

Do analysts recommend CNC or HUM?

Which has better earnings & valuation, CNC or HUM?

Do insiders & institutionals believe in CNC or HUM?

Does the media refer more to CNC or HUM?

Summary

How does Centene compare to Oscar Health?

Which has stronger valuation and earnings, OSCR or CNC?

Is OSCR or CNC more profitable?

Do analysts recommend OSCR or CNC?

Which has more volatility & risk, OSCR or CNC?

Do insiders and institutionals believe in OSCR or CNC?

Does the media refer more to OSCR or CNC?

Summary

How does Centene compare to HealthEquity?

Does the media favor HQY or CNC?

Is HQY or CNC more profitable?

Do analysts rate HQY or CNC?

Which has more volatility and risk, HQY or CNC?

Do institutionals & insiders have more ownership in HQY or CNC?

Which has better valuation & earnings, HQY or CNC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNC vs. The Competition

Centene Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools